Literature DB >> 7378378

Band 3-glycophorin A association in erythrocyte membrane demonstrated by combining protein diffusion measurements with antibody-induced cross-linking.

E A Nigg, C Bron, M Girardet, R J Cherry.   

Abstract

A new approach to the study of molecular protein interactions in biological membranes is presented. The technique is based on measuring the rotation of a membrane protein in the presence and absence of specific antibodies directed toward a purported complex partner. As a first illustration of the method, the putative association of band 3 with glycophorin A in the human erythrocyte membrane was investigated. The rotational diffusion of band 3 was strongly reduced following cross-linking of glycophorin A with divalent antibodies. However, little or no effect on band 3 rotation was produced by monovalent antiglycophorin A Fab fragments, antispectrinor nonspecific antibodies, ruling out major effects on band 3 mobility due to steric hindrance, unspecific antibody adsorption, or transmembrane interactions involving spectrin. It is concluded that immobilization of band 3 by antiglycophorin A antibodies is directly caused by cross-linking of a preexisting band 3-glycophorin A complex in the human erythrocyte membrane.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378378     DOI: 10.1021/bi00550a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Human erythrocyte band 3 functions as a receptor for the sialic acid-independent invasion of Plasmodium falciparum. Role of the RhopH3-MSP1 complex.

Authors:  Michael Baldwin; Innocent Yamodo; Ravi Ranjan; Xuerong Li; Gregory Mines; Marina Marinkovic; Toshihiko Hanada; Steven S Oh; Athar H Chishti
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Kinematics of red cell aspiration by fluorescence-imaged microdeformation.

Authors:  D E Discher; N Mohandas
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

3.  Monoclonal antibodies to the membrane domain of the human erythrocyte anion transport protein. Localization of the C-terminus of the protein to the cytoplasmic side of the red cell membrane and distribution of the protein in some human tissues.

Authors:  S D Wainwright; M J Tanner; G E Martin; J E Yendle; C Holmes
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

4.  The Dantu erythrocyte phenotype of the NE variety. II. Serology, immunochemistry, genetics, and frequency.

Authors:  P Unger; J L Procter; J J Moulds; M Moulds; D Blanchard; M L Guizzo; L A McCall; J P Cartron; W Dahr
Journal:  Blut       Date:  1987-07

5.  Full-Length Anion Exchanger 1 Structure and Interactions with Ankyrin-1 Determined by Zero Length Crosslinking of Erythrocyte Membranes.

Authors:  Roland Rivera-Santiago; Sandra L Harper; Sira Sriswasdi; Peter Hembach; David W Speicher
Journal:  Structure       Date:  2016-12-15       Impact factor: 5.006

6.  Loss of rotational mobility of band 3 proteins in human erythrocyte membranes induced by antibodies to glycophorin A.

Authors:  A Che; R J Cherry
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

7.  Differential control of band 3 lateral and rotational mobility in intact red cells.

Authors:  J D Corbett; P Agre; J Palek; D E Golan
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  Trafficking defects of the Southeast Asian ovalocytosis deletion mutant of anion exchanger 1 membrane proteins.

Authors:  Joanne C Cheung; Emmanuelle Cordat; Reinhart A F Reithmeier
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

9.  The influence of melittin on the rotation of band 3 protein in the human erythrocyte membrane.

Authors:  M J Dufton; R C Hider; R J Cherry
Journal:  Eur Biophys J       Date:  1984       Impact factor: 1.733

10.  Protein 4.1: its association with the human erythrocyte membrane.

Authors:  K A Shiffer; S R Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.